Flow cytometric analysis of cytokine receptor signal transduction

Journal of Immunological Methods

Volumn 278, Issue 1-2, 2003, Pages 221-234

  Ilangumaran, Subburaj ^a   Finan, Dina ^a   Rottapel, Robert ^a,b,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cytokines; Flow cytometry; Hematopoiesis; Signal transduction; STAT

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; JANUS KINASE; PROTEIN; STAT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL TYPE; CLINICAL PATHWAY; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIESIS; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THYMOCYTE; WESTERN BLOTTING;

EID: 0142071105     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00177-7     Document Type: Article

References (31)

1. Brugnera E., Bhandoola A., Cibotti R., Yu Q., Guinter T.I., Yamashita Y., Sharrow S.O., Singer A. Coreceptor reversal in the thymus: signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells. Immunity. 13:2000;59-71.
2. Candotti F., Notarangelo L., Visconti R., O'Shea J. Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways. J. Clin. Invest. 109:2002;1261-1269.
3. Chow S., Patel H., Hedley D.W. Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry. 46:2001;72-78.
4. Cohen P. The regulation of protein function by multisite phosphorylation - a 25 year update. Trends Biochem. Sci. 25:2000;596-601.
5. Fleisher T.A., Dorman S.E., Anderson J.A., Vail M., Brown M.R., Holland S.M. Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin. Immunol. 90:1999;425-430.
6. Frackelton A.R. Jr., Posner M., Kannan B., Mermelstein F. Generation of monoclonal antibodies against phosphotyrosine and their use for affinity purification of phosphotyrosine-containing proteins. Methods Enzymol. 201:1991;79-92.
7. Giri J.G., Anderson D.M., Kumaki S., Park L.S., Grabstein K.H., Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukoc. Biol. 57:1995;763-766.
8. Giri J.G., Kumaki S., Ahdieh M., Friend D.J., Loomis A., Shanebeck K., DuBose R., Cosman D., Park L.S., Anderson D.M. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 14:1995;3654-3663.
9. Glenney J.R. Isolation of tyrosine-phosphorylated proteins and generation of monoclonal antibodies. Methods Enzymol. 201:1991;92-100.
10. Heffetz D., Fridkin M., Zick Y. Generation and use of antibodies to phosphothreonine. Methods Enzymol. 201:1991;44-53.
11. Johnston J.A., Wang L.M., Hanson E.P., Sun X.J., White M.F., Oakes S.A., Pierce J.H., O'Shea J.J. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J. Biol. Chem. 270:1995;28527-28530.
12. Kamps M.P. Generation and use of anti-phosphotyrosine antibodies for immunoblotting. Methods Enzymol. 201:1991;101-110.
13. Leonard W.J. Type I cytokines and interferons and their receptors. Paul W.E. Fundamental Immunology. 1999;741-774 Lippincott-Raven Publishers, Philadelphia.
14. Leonard W.J., Lin J.X. Cytokine receptor signaling pathways. J. Allergy Clin. Immunol. 105:2000;877-888.
15. Lin J.X., Migone T.S., Tsang M., Friedmann M., Weatherbee J.A., Zhou L., Yamauchi A., Bloom E.T., Mietz J., John S.et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity. 2:1995;331-339.
16. Marks-Konczalik J., Dubois S., Losi J.M., Sabzevari H., Yamada N., Feigenbaum L., Waldmann T.A., Tagaya Y. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 97:2000;11445-11450.
17. Marrack P., Bender J., Hildeman D., Jordan M., Mitchell T., Murakami M., Sakamoto A., Schaefer B.C., Swanson B., Kappler J. Homeostasis of alpha beta TCR+ T cells. Nat. Immunol. 1:2000;107-111.
18. O'Shea J.J., Gadina M., Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 109:2002;S121-S131. (Suppl.).
19. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., Park L.S., Ziegler S.F., Williams D.E., Ware C.B.et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1994;1955-1960.
20. Rane S.G., Reddy E.P. Janus kinases: components of multiple signaling pathways. Oncogene. 19:2000;5662-5679.
21. Reith W., Mach B. The bare lymphocyte syndrome and the regulation of mhc expression. Annu. Rev. Immunol. 19:2001;331-373.
22. Rodewald H.R., Ogawa M., Haller C., Waskow C., DiSanto J.P. Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. Immunity. 6:1997;265-272.
23. Tagaya Y., Bamford R.N., DeFilippis A.P., Waldmann T.A. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity. 4:1996;329-336.
24. Turkson J., Jove R. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene. 19:2000;6613-6626.
25. Uzel G., Frucht D.M., Fleisher T.A., Holland S.M. Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin. Immunol. 100:2001;270-276.
26. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1995;1519-1526.
27. Watowich S.S., Wu H., Socolovsky M., Klingmuller U., Constantinescu S.N., Lodish H.F. Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu. Rev. Cell Dev. Biol. 12:1996;91-128.
28. Wells A.D., Gudmundsdottir H., Turka L.A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100:1997;3173-3183.
29. Wu T.S., Lee J.M., Lai Y.G., Hsu J.C., Tsai C.Y., Lee Y.H., Liao N.S. Reduced expression of Bcl-2 in CD8+ T cells deficient in the IL-15 receptor alpha-chain. J. Immunol. 168:2002;705-712.
30. Yasukawa H., Sasaki A., Yoshimura A. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18:2000;143-164.
31. Zuniga-Pflucker J.C., Lenardo M.J. Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8:1996;215-224.